Find and Pitch Jounalists, Get Your Story Covered

Tags: acxiom arthur sadoun elon musk huge ipg

	Profile	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Keytruda Not Cost-Effective in Locally Advanced Cervical Cancer, Study Says - about 1 month ago Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 7 months ago No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer - 7 months ago Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies - 9 months ago Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT - 9 months ago Chemotherapy/ICI Combos Falter as Second-Line Treatment for Gastric Cancer - about 1 year ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - about 1 year ago Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results - about 1 year ago New First-Line Option for Pancreatic Cancer Approved - about 1 year ago Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancer - about 1 year ago Language Minimizing Adverse Events; HPV and Thyroid Cancer; Ultrasound Bras - over 1 year ago Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug - over 1 year ago
2	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Advances in Cancer Therapies and Diagnostics - 3 months ago Circumventing Cancer Resistance - 4 months ago
3	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Tislelizumab in Combination With Chemotherapy for Gastric, Gastrosophageal Junction Adenocarcinoma - 3 months ago Study: Sex-Specific Disparities Found Across Various Cancer Types - about 1 year ago Dostarlimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit in Endometrial Cancer - about 1 year ago Pembrolizumab, Chemoradiotherapy Meet Overall Survival Endpoint for Cervical Cancer - about 1 year ago FDA Approves Capivasertib With Fulvestrant for PIK3CA/ALT1/PTEN Alterations Breast Cancer - over 1 year ago
4	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Sequencing in Advanced Urothelial Carcinoma - 5 months ago KEYNOTE-A18 Data Are 'Practice-Changing' for Cervical Cancer - over 1 year ago The Treatment Landscape for Cervical Cancer Has Changed - over 1 year ago Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer - over 1 year ago Uterine Cancer Trials Made Waves This Year, Experts Say - over 1 year ago
5	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: A drug may cause problems with chemotherapies in cancer patients with obesity. Many doctors are in the dark - 6 months ago
6	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial - 7 months ago STAT+: Results on Novartis prostate cancer therapy could expand its use - over 1 year ago
7	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment - 9 months ago
8	Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. HealthcareEditing	The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer - 9 months ago
9	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Navigating Oncology Drug Shortages: Ethical Frameworks and Strategic Management - 10 months ago
10	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Ahead of ASCO, J&J reports mixed data on next-generation radiopharmaceutical - 11 months ago

Journalists covering cisplatin,cisplatin-based chemotherapy,testicular cancer,cervical cancer,hearing loss